Drug Database
Back to search

Germany· DE-A57-8d03a02c8630bf6b

Metopiron

A metyrapone product containing metyrapone, registered in Germany by Hra Pharma Rare Diseases. The same ATC class is registered in 14 of our 19 countries.

ATC V04CD01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedMetopironATCV04CD01REGISTER NO.DE-A57-8d03a02c8630bf…PACKS LISTED0CHECKEDSeptember 23, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about metyraponeAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metyrapone is registered in 14 of 19 countries.

Countries holding a registration under ATC V04CD01 (metyrapone), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search metyrapone products by name

Metyrapone · ATC V04CD01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of metyrapone costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Metyrapone · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$91.87
  • FR France$70.58
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Metyrapone
Manufacturer
Hra Pharma Rare Diseases
Country
Germany (DE)
ATC code
V04CD01
ATC class
Metyrapone
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 23, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

14 interactions on record for metyrapone.

Graded by severity as the source publishes them — 14 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metyrapone against other medicinesHow interaction checks work

Metyrapone · interactions on record

14 records

  • 14 moderate

Most severe, free to view

  • CyproheptadinA15AA01moderate
  • EstradiolD11AX34moderate
  • Levonorgestrel and ethinylestradiolG03AA07moderate
  • Desogestrel and ethinylestradiolG03AA09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Metyrapone in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metyrapone products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Metycor
  • Bulgaria · Metopirone
  • Czechia · Metopirone
  • Denmark · Metopirone
  • Estonia · Cormeto
  • Spain · Metopirone
  • Finland · Metopirone
  • France · Metyrapone Esteve
  • Greece · Metopirone
  • Croatia · Metopirone
  • Hungary · Cormeto
  • Ireland · Metopirone
  • Italy · Cormeto
  • Lithuania · Cormeto
  • Latvia · Metopirone
  • Netherlands · Metopirone
  • Norway · Metycor
  • Poland · Metopirone
  • Portugal · Metopirone Esteve Pharmaceuticals
  • Romania · Metopirone
  • Sweden · Metopirone
  • Slovenia · Metycor
  • Slovakia · Metopirone

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/71b6d4d7-0eb8-4b17-87c0-af4935e5952d
GET /v1/drugs/71b6d4d7-0eb8-4b17-87c0-af4935e5952d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Metyrapone",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about metyrapone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console